Williams & Novak’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.33M Buy
4,055
+44
+1% +$13.7K 0.79% 38
2026
Q2
$1.74M Buy
4,011
+42
+1% +$12.8K 1.15% 22
2026
Q1
$881K Buy
3,969
+106
+3% +$23.7K 0.66% 42
2025
Q4
$661K Buy
3,863
+113
+3% +$17.6K 0.5% 52
2025
Q3
$502K Hold
3,750
– – 0.39% 63
2025
Q2
$365K Hold
3,750
– – 0.31% 77
2025
Q1
$273K Buy
+3,750
New +$295K 0.27% 87
2024
Q4
– Sell
-3,750
Closed -$306K – 136
2024
Q3
$306K Hold
3,750
– – 0.29% 84
2024
Q2
$399K Hold
3,750
– – 0.37% 63
2024
Q1
$294K Hold
3,750
– – 0.33% 68
2023
Q4
$294K Buy
+3,750
New +$256K 0.33% 68

Other funds holding LRCX

Williams & Novak's LRCX Position: Q3 2026 in Review

Williams & Novak increased its Lam Research (LRCX) stake by 1.1% in Q3 2026, buying an estimated $13.7K and bringing the position to 4,055 shares worth $1.33M. The position accounts for 0.79% of the portfolio, ranked #38.

Williams & Novak first reported a position in LRCX in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.74M in Q2 2026. 1,901 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Williams & Novak held 4,055 shares of Lam Research worth $1.33M as of Q3 2026.
  • Williams & Novak bought 44 Lam Research shares in Q3 2026, an estimated $13.7K.
  • Lam Research made up 0.79% of Williams & Novak's portfolio in Q3 2026, its #38 holding.
  • Williams & Novak first reported a position in Lam Research in Q4 2023 and has held it in 11 quarters since.
  • Williams & Novak's Lam Research position peaked at $1.74M in Q2 2026.
  • 1,901 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Williams & Novak's 13F filing for Q3 2026, filed 9 Oct 2026.